

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.33671238 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 5.19732632 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.07358616 |
| 4 | vocalization behavior (GO:0071625) | 5.01625224 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.63802082 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.53194725 |
| 7 | glutamate secretion (GO:0014047) | 4.46192731 |
| 8 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.45993455 |
| 9 | protein localization to synapse (GO:0035418) | 4.37720747 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.36813558 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.35297137 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.34049369 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.33782551 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.31465056 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.31261272 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.26336537 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.24960285 |
| 18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.17079492 |
| 19 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.08105612 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.07235057 |
| 21 | neuron recognition (GO:0008038) | 4.07198583 |
| 22 | presynaptic membrane assembly (GO:0097105) | 3.98271500 |
| 23 | exploration behavior (GO:0035640) | 3.88476479 |
| 24 | response to histamine (GO:0034776) | 3.87667331 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.87603596 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.87276999 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.84609189 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 3.80510616 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.79812522 |
| 30 | presynaptic membrane organization (GO:0097090) | 3.75248751 |
| 31 | long-term synaptic potentiation (GO:0060291) | 3.72679786 |
| 32 | nucleobase catabolic process (GO:0046113) | 3.64094903 |
| 33 | synaptic vesicle endocytosis (GO:0048488) | 3.63543823 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.61999284 |
| 35 | regulation of glutamate secretion (GO:0014048) | 3.56008312 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.55204809 |
| 37 | proline transport (GO:0015824) | 3.54597199 |
| 38 | neurotransmitter transport (GO:0006836) | 3.52523395 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.51841087 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.48035711 |
| 41 | negative regulation of neurotransmitter transport (GO:0051589) | 3.47016223 |
| 42 | axonal fasciculation (GO:0007413) | 3.46402278 |
| 43 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.44919256 |
| 44 | * ATP hydrolysis coupled proton transport (GO:0015991) | 3.44919256 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.41650243 |
| 46 | mating behavior (GO:0007617) | 3.32444020 |
| 47 | negative regulation of dendrite development (GO:2000171) | 3.31796614 |
| 48 | long-term memory (GO:0007616) | 3.29324660 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.28987916 |
| 50 | nerve growth factor signaling pathway (GO:0038180) | 3.28971054 |
| 51 | regulation of vesicle fusion (GO:0031338) | 3.28912051 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.28440177 |
| 53 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.27493730 |
| 54 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27151608 |
| 55 | cellular potassium ion homeostasis (GO:0030007) | 3.25212677 |
| 56 | * transferrin transport (GO:0033572) | 3.25046825 |
| 57 | regulation of synaptic plasticity (GO:0048167) | 3.23422117 |
| 58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.21513991 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21179146 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.18292622 |
| 61 | behavioral response to cocaine (GO:0048148) | 3.17916481 |
| 62 | protein localization to cilium (GO:0061512) | 3.17619648 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.17517249 |
| 64 | startle response (GO:0001964) | 3.14778922 |
| 65 | behavioral fear response (GO:0001662) | 3.13855341 |
| 66 | behavioral defense response (GO:0002209) | 3.13855341 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.13635306 |
| 68 | positive regulation of membrane potential (GO:0045838) | 3.11921112 |
| 69 | postsynaptic membrane organization (GO:0001941) | 3.11448647 |
| 70 | positive regulation of synapse assembly (GO:0051965) | 3.09522958 |
| 71 | detection of calcium ion (GO:0005513) | 3.09209874 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 3.07645249 |
| 73 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.06730961 |
| 74 | fear response (GO:0042596) | 3.03352266 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 3.03216403 |
| 76 | * ferric iron transport (GO:0015682) | 3.03188694 |
| 77 | * trivalent inorganic cation transport (GO:0072512) | 3.03188694 |
| 78 | establishment of synaptic vesicle localization (GO:0097480) | 3.02301057 |
| 79 | synaptic vesicle transport (GO:0048489) | 3.02301057 |
| 80 | negative regulation of amino acid transport (GO:0051956) | 3.00735487 |
| 81 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00259326 |
| 82 | dendritic spine morphogenesis (GO:0060997) | 2.99324040 |
| 83 | righting reflex (GO:0060013) | 2.98835401 |
| 84 | regulation of synapse structural plasticity (GO:0051823) | 2.98468645 |
| 85 | synaptic transmission, dopaminergic (GO:0001963) | 2.98046311 |
| 86 | vesicle transport along microtubule (GO:0047496) | 2.96832832 |
| 87 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.96233220 |
| 88 | synapse assembly (GO:0007416) | 2.95852466 |
| 89 | membrane depolarization (GO:0051899) | 2.90998943 |
| 90 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90644328 |
| 91 | learning (GO:0007612) | 2.89917734 |
| 92 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.88815162 |
| 93 | synaptic transmission (GO:0007268) | 2.88009943 |
| 94 | * phagosome maturation (GO:0090382) | 2.85788595 |
| 95 | ganglioside metabolic process (GO:0001573) | 2.84250055 |
| 96 | regulation of neurotransmitter transport (GO:0051588) | 2.83659668 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.82771300 |
| 98 | regulation of protein kinase A signaling (GO:0010738) | 2.82569461 |
| 99 | dopamine biosynthetic process (GO:0042416) | 2.82044145 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81863246 |
| 101 | establishment of vesicle localization (GO:0051650) | 2.80189654 |
| 102 | acidic amino acid transport (GO:0015800) | 2.79308233 |
| 103 | regulation of synaptic transmission (GO:0050804) | 2.78021904 |
| 104 | neuron remodeling (GO:0016322) | 2.77532101 |
| 105 | negative regulation of synaptic transmission (GO:0050805) | 2.77399963 |
| 106 | positive regulation of synaptic transmission (GO:0050806) | 2.76282912 |
| 107 | synapse organization (GO:0050808) | 2.75525797 |
| 108 | regulation of dendritic spine development (GO:0060998) | 2.75493347 |
| 109 | membrane hyperpolarization (GO:0060081) | 2.75321204 |
| 110 | peptidyl-cysteine modification (GO:0018198) | 2.75224042 |
| 111 | long term synaptic depression (GO:0060292) | 2.75072516 |
| 112 | dendritic spine organization (GO:0097061) | 2.74629648 |
| 113 | clathrin coat assembly (GO:0048268) | 2.74370742 |
| 114 | positive regulation of neurotransmitter transport (GO:0051590) | 2.73341629 |
| 115 | glycosphingolipid biosynthetic process (GO:0006688) | 2.72976701 |
| 116 | response to dietary excess (GO:0002021) | 2.69062167 |
| 117 | melanosome transport (GO:0032402) | 2.66000508 |
| 118 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.64900362 |
| 119 | vesicle docking (GO:0048278) | 2.64729958 |
| 120 | neurotransmitter uptake (GO:0001504) | 2.64388534 |
| 121 | positive regulation of exocytosis (GO:0045921) | 2.63561493 |
| 122 | establishment of melanosome localization (GO:0032401) | 2.63174890 |
| 123 | regulation of feeding behavior (GO:0060259) | 2.61862015 |
| 124 | vesicle docking involved in exocytosis (GO:0006904) | 2.60915110 |
| 125 | regulation of exocytosis (GO:0017157) | 2.58145830 |
| 126 | glycosphingolipid catabolic process (GO:0046479) | 2.58027552 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57149822 |
| 128 | pigment granule transport (GO:0051904) | 2.56578203 |
| 129 | dendrite morphogenesis (GO:0048813) | 2.56143937 |
| 130 | signal release (GO:0023061) | 2.55450907 |
| 131 | establishment of pigment granule localization (GO:0051905) | 2.54285103 |
| 132 | cellular response to ethanol (GO:0071361) | 2.53690794 |
| 133 | oligosaccharide catabolic process (GO:0009313) | 2.53449972 |
| 134 | C4-dicarboxylate transport (GO:0015740) | 2.53430741 |
| 135 | * iron ion transport (GO:0006826) | 2.52623121 |
| 136 | L-glutamate transport (GO:0015813) | 2.52250781 |
| 137 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.50603984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.64357634 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.19841125 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08915365 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98477208 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.88903326 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.79324557 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65066274 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.48507701 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46298098 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46298098 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44748184 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44617979 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42573006 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.34989299 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34256627 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28567534 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.28378627 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.26595238 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.22753623 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21297312 |
| 21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.14955620 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97551014 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97515386 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93195104 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92547793 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.91667815 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89141995 |
| 28 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.88013434 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87328556 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86883202 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86118517 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84558342 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.84346159 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81007412 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.79630289 |
| 36 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78124167 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77175825 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71514491 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69120802 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66170596 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65751480 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.64779051 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.64211500 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63655869 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.62847394 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62368243 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.62118777 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.61636301 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60909861 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58540428 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58259744 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57305496 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56440598 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53340483 |
| 55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51682857 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50743591 |
| 57 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.50610177 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48538080 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48501030 |
| 60 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.47406266 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.46863033 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42974126 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41995436 |
| 64 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.41561844 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41017523 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39503654 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39371492 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39371492 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38592886 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36047927 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33919036 |
| 72 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33847799 |
| 73 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.32881770 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31768965 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31341748 |
| 76 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30802637 |
| 77 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.30446462 |
| 78 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.29875155 |
| 79 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29628881 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28600719 |
| 81 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28464363 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27666322 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24898701 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23437793 |
| 85 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23281791 |
| 86 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22677559 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 1.22380702 |
| 88 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21612328 |
| 89 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19389130 |
| 90 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19143311 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17682039 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17250009 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.17215942 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17125133 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16734521 |
| 96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16535229 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16309185 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15866812 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14927389 |
| 100 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14801737 |
| 101 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.14663296 |
| 102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14206789 |
| 103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.13310905 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13122048 |
| 105 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13045153 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11380804 |
| 107 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11366138 |
| 108 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11266263 |
| 109 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10429495 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09290304 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09060757 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08462857 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07483549 |
| 114 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.06421944 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06198866 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05081654 |
| 117 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.05026352 |
| 118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.04885806 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04463556 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03933774 |
| 121 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03341805 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02988790 |
| 123 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01971628 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 1.01639417 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00958972 |
| 126 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.98931735 |
| 127 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98647014 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97872498 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97872498 |
| 130 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96423696 |
| 131 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95880776 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92759393 |
| 133 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92539812 |
| 134 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92289125 |
| 135 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91985051 |
| 136 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91299377 |
| 137 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89524758 |
| 138 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89371988 |
| 139 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89371988 |
| 140 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89220584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.72327172 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.33503589 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.92565588 |
| 4 | MP0009745_abnormal_behavioral_response | 3.46960123 |
| 5 | MP0002064_seizures | 3.40555943 |
| 6 | MP0009046_muscle_twitch | 3.33301012 |
| 7 | MP0004270_analgesia | 3.25855769 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.19377812 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.13661240 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.87778271 |
| 11 | MP0002736_abnormal_nociception_after | 2.77777422 |
| 12 | MP0002272_abnormal_nervous_system | 2.68225905 |
| 13 | MP0003195_calcinosis | 2.66558962 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.64123149 |
| 15 | MP0001440_abnormal_grooming_behavior | 2.63734321 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.49357771 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.45970226 |
| 18 | MP0001486_abnormal_startle_reflex | 2.38744624 |
| 19 | MP0003329_amyloid_beta_deposits | 2.24531316 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.24259976 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.21421940 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.15237573 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.12118434 |
| 24 | MP0001529_abnormal_vocalization | 2.07366099 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.04625884 |
| 26 | MP0001970_abnormal_pain_threshold | 1.98273226 |
| 27 | MP0002822_catalepsy | 1.93470995 |
| 28 | MP0001905_abnormal_dopamine_level | 1.92659955 |
| 29 | MP0004924_abnormal_behavior | 1.86684899 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.86684899 |
| 31 | MP0000778_abnormal_nervous_system | 1.85343824 |
| 32 | MP0002184_abnormal_innervation | 1.79724506 |
| 33 | MP0002102_abnormal_ear_morphology | 1.68480903 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.65941955 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.65666985 |
| 36 | MP0001984_abnormal_olfaction | 1.62968173 |
| 37 | MP0002557_abnormal_social/conspecific_i | 1.61796997 |
| 38 | MP0008569_lethality_at_weaning | 1.50301079 |
| 39 | MP0004142_abnormal_muscle_tone | 1.49428730 |
| 40 | MP0001188_hyperpigmentation | 1.47586477 |
| 41 | MP0003121_genomic_imprinting | 1.45565378 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.44040880 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.43377219 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.40164761 |
| 45 | MP0000604_amyloidosis | 1.36844491 |
| 46 | MP0000955_abnormal_spinal_cord | 1.36385480 |
| 47 | MP0002882_abnormal_neuron_morphology | 1.35626939 |
| 48 | MP0003879_abnormal_hair_cell | 1.34953405 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.34226208 |
| 50 | MP0003122_maternal_imprinting | 1.34080370 |
| 51 | MP0004858_abnormal_nervous_system | 1.34026259 |
| 52 | MP0004742_abnormal_vestibular_system | 1.32547519 |
| 53 | MP0005248_abnormal_Harderian_gland | 1.29153344 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.29053113 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.27393285 |
| 56 | MP0005253_abnormal_eye_physiology | 1.26975162 |
| 57 | MP0004885_abnormal_endolymph | 1.26070554 |
| 58 | MP0003633_abnormal_nervous_system | 1.25528156 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.24771262 |
| 60 | MP0003631_nervous_system_phenotype | 1.17267045 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.16151139 |
| 62 | MP0000920_abnormal_myelination | 1.15893119 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.14646843 |
| 64 | MP0006082_CNS_inflammation | 1.12981404 |
| 65 | MP0002229_neurodegeneration | 1.12895230 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.10982007 |
| 67 | MP0010678_abnormal_skin_adnexa | 1.09600397 |
| 68 | MP0003787_abnormal_imprinting | 1.09595670 |
| 69 | MP0000371_diluted_coat_color | 1.09201057 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.08069108 |
| 71 | MP0003634_abnormal_glial_cell | 1.07625752 |
| 72 | MP0003690_abnormal_glial_cell | 1.05719341 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.05058060 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.04150911 |
| 75 | MP0008877_abnormal_DNA_methylation | 1.03322841 |
| 76 | MP0003632_abnormal_nervous_system | 1.02990306 |
| 77 | MP0005171_absent_coat_pigmentation | 0.99739131 |
| 78 | MP0002152_abnormal_brain_morphology | 0.99033723 |
| 79 | MP0001963_abnormal_hearing_physiology | 0.96944402 |
| 80 | MP0002090_abnormal_vision | 0.96749723 |
| 81 | MP0004484_altered_response_of | 0.95143027 |
| 82 | MP0005535_abnormal_body_temperature | 0.94672743 |
| 83 | MP0002163_abnormal_gland_morphology | 0.94587959 |
| 84 | MP0000013_abnormal_adipose_tissue | 0.93329004 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.90082154 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.89690630 |
| 87 | MP0008874_decreased_physiological_sensi | 0.87427256 |
| 88 | MP0008872_abnormal_physiological_respon | 0.87294235 |
| 89 | MP0005409_darkened_coat_color | 0.87292901 |
| 90 | MP0000427_abnormal_hair_cycle | 0.87080212 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.86447868 |
| 92 | MP0005187_abnormal_penis_morphology | 0.83001450 |
| 93 | MP0001324_abnormal_eye_pigmentation | 0.81727574 |
| 94 | MP0004147_increased_porphyrin_level | 0.79950476 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.79883630 |
| 96 | MP0001756_abnormal_urination | 0.78896891 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.78850642 |
| 98 | MP0001177_atelectasis | 0.77827103 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.77556674 |
| 100 | MP0003123_paternal_imprinting | 0.75010359 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.74210366 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.73919470 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.72149614 |
| 104 | MP0001664_abnormal_digestion | 0.71594884 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.71435622 |
| 106 | MP0005499_abnormal_olfactory_system | 0.71435622 |
| 107 | MP0000751_myopathy | 0.70951304 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.70478236 |
| 109 | MP0000516_abnormal_urinary_system | 0.70478236 |
| 110 | MP0004043_abnormal_pH_regulation | 0.68457879 |
| 111 | MP0004085_abnormal_heartbeat | 0.67121784 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.66896235 |
| 113 | MP0005408_hypopigmentation | 0.66423683 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.64903305 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.62960252 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.60427756 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.59409974 |
| 118 | MP0000026_abnormal_inner_ear | 0.58780076 |
| 119 | MP0001943_abnormal_respiration | 0.56736055 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.54710594 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.54414245 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.52750137 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.52723180 |
| 124 | MP0004510_myositis | 0.52492811 |
| 125 | MP0003075_altered_response_to | 0.48703024 |
| 126 | MP0005410_abnormal_fertilization | 0.48444060 |
| 127 | MP0003956_abnormal_body_size | 0.44291973 |
| 128 | MP0004233_abnormal_muscle_weight | 0.44230201 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.43864079 |
| 130 | MP0010770_preweaning_lethality | 0.42836953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.68153779 |
| 2 | Focal seizures (HP:0007359) | 5.47351269 |
| 3 | Atonic seizures (HP:0010819) | 5.28607049 |
| 4 | Visual hallucinations (HP:0002367) | 5.22053475 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.84111159 |
| 6 | Myokymia (HP:0002411) | 4.63882098 |
| 7 | Absence seizures (HP:0002121) | 4.61732866 |
| 8 | Dialeptic seizures (HP:0011146) | 4.38157145 |
| 9 | Hyperventilation (HP:0002883) | 4.37497100 |
| 10 | Febrile seizures (HP:0002373) | 4.32027712 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.31636546 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.16404079 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.16404079 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.16404079 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.97844225 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.89841113 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.80631841 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.78084605 |
| 19 | Broad-based gait (HP:0002136) | 3.46605314 |
| 20 | Truncal ataxia (HP:0002078) | 3.15269152 |
| 21 | Progressive inability to walk (HP:0002505) | 3.09403508 |
| 22 | Amblyopia (HP:0000646) | 3.02861368 |
| 23 | Papillary thyroid carcinoma (HP:0002895) | 3.00780285 |
| 24 | Diplopia (HP:0000651) | 2.99032387 |
| 25 | Abnormality of binocular vision (HP:0011514) | 2.99032387 |
| 26 | Disinhibition (HP:0000734) | 2.95508798 |
| 27 | Excessive salivation (HP:0003781) | 2.92743136 |
| 28 | Drooling (HP:0002307) | 2.92743136 |
| 29 | Pheochromocytoma (HP:0002666) | 2.92426090 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.88651672 |
| 31 | Dysmetria (HP:0001310) | 2.87718834 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.81957281 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.81386311 |
| 34 | Limb dystonia (HP:0002451) | 2.80262984 |
| 35 | Insidious onset (HP:0003587) | 2.79770572 |
| 36 | Termporal pattern (HP:0011008) | 2.79770572 |
| 37 | Apathy (HP:0000741) | 2.78979328 |
| 38 | Polyphagia (HP:0002591) | 2.78569339 |
| 39 | Action tremor (HP:0002345) | 2.74094602 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.72876363 |
| 41 | Mutism (HP:0002300) | 2.72598519 |
| 42 | Anxiety (HP:0000739) | 2.70172467 |
| 43 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.68228370 |
| 44 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.68228370 |
| 45 | Neuroendocrine neoplasm (HP:0100634) | 2.67997815 |
| 46 | Abnormality of the corticospinal tract (HP:0002492) | 2.67555358 |
| 47 | Hypothermia (HP:0002045) | 2.67108715 |
| 48 | Diminished motivation (HP:0000745) | 2.65674375 |
| 49 | Absent speech (HP:0001344) | 2.64114525 |
| 50 | Inability to walk (HP:0002540) | 2.60241349 |
| 51 | Poor eye contact (HP:0000817) | 2.58923475 |
| 52 | Thyroid carcinoma (HP:0002890) | 2.57207338 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.56165913 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.54370991 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.48252685 |
| 56 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.46849894 |
| 57 | Abnormal social behavior (HP:0012433) | 2.42351305 |
| 58 | Impaired social interactions (HP:0000735) | 2.42351305 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.41892002 |
| 60 | Generalized myoclonic seizures (HP:0002123) | 2.41185609 |
| 61 | Depression (HP:0000716) | 2.40998793 |
| 62 | Hemiparesis (HP:0001269) | 2.40699460 |
| 63 | Gait imbalance (HP:0002141) | 2.40583432 |
| 64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.36252239 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.33508125 |
| 66 | Amyotrophic lateral sclerosis (HP:0007354) | 2.32584267 |
| 67 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.31914862 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31452740 |
| 69 | Delusions (HP:0000746) | 2.30572113 |
| 70 | Muscular hypotonia of the trunk (HP:0008936) | 2.28430018 |
| 71 | Scanning speech (HP:0002168) | 2.28162408 |
| 72 | Increased circulating renin level (HP:0000848) | 2.26795435 |
| 73 | Agnosia (HP:0010524) | 2.26695794 |
| 74 | Spinal muscular atrophy (HP:0007269) | 2.24330383 |
| 75 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.23201669 |
| 76 | Akinesia (HP:0002304) | 2.21493252 |
| 77 | Retinal atrophy (HP:0001105) | 2.21344888 |
| 78 | Psychosis (HP:0000709) | 2.20730196 |
| 79 | Abnormality of the anterior horn cell (HP:0006802) | 2.18453167 |
| 80 | Degeneration of anterior horn cells (HP:0002398) | 2.18453167 |
| 81 | Bradykinesia (HP:0002067) | 2.17853975 |
| 82 | Ankle clonus (HP:0011448) | 2.17713673 |
| 83 | Loss of speech (HP:0002371) | 2.15505151 |
| 84 | Spastic gait (HP:0002064) | 2.14523334 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14217461 |
| 86 | Hypsarrhythmia (HP:0002521) | 2.13625765 |
| 87 | Tetraparesis (HP:0002273) | 2.12406783 |
| 88 | Postural instability (HP:0002172) | 2.11263464 |
| 89 | Protruding tongue (HP:0010808) | 2.10956696 |
| 90 | Blue irides (HP:0000635) | 2.10468625 |
| 91 | Fetal akinesia sequence (HP:0001989) | 2.10341676 |
| 92 | Clumsiness (HP:0002312) | 2.09684950 |
| 93 | Medial flaring of the eyebrow (HP:0010747) | 2.08603061 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 2.08578041 |
| 95 | Congenital primary aphakia (HP:0007707) | 2.08518934 |
| 96 | Mitochondrial inheritance (HP:0001427) | 2.07151680 |
| 97 | Hypomagnesemia (HP:0002917) | 2.05560633 |
| 98 | Abnormality of salivation (HP:0100755) | 2.05196274 |
| 99 | Intestinal atresia (HP:0011100) | 2.02127492 |
| 100 | Urinary urgency (HP:0000012) | 2.01914829 |
| 101 | Epidermoid cyst (HP:0200040) | 2.01362848 |
| 102 | Intention tremor (HP:0002080) | 2.00659314 |
| 103 | Paraplegia (HP:0010550) | 1.97617691 |
| 104 | Hypokalemic alkalosis (HP:0001949) | 1.96963276 |
| 105 | Hypoglycemic coma (HP:0001325) | 1.96944075 |
| 106 | Inappropriate behavior (HP:0000719) | 1.96287919 |
| 107 | Status epilepticus (HP:0002133) | 1.95813966 |
| 108 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95503195 |
| 109 | Impaired smooth pursuit (HP:0007772) | 1.95258469 |
| 110 | Gait ataxia (HP:0002066) | 1.94317643 |
| 111 | Esotropia (HP:0000565) | 1.94085030 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.92663467 |
| 113 | Genital tract atresia (HP:0001827) | 1.92544653 |
| 114 | Neoplasm of the adrenal cortex (HP:0100641) | 1.92485953 |
| 115 | Rapidly progressive (HP:0003678) | 1.91896031 |
| 116 | Vaginal atresia (HP:0000148) | 1.91552920 |
| 117 | Widely spaced teeth (HP:0000687) | 1.91057335 |
| 118 | Hypoglycemic seizures (HP:0002173) | 1.90372999 |
| 119 | Retinal dysplasia (HP:0007973) | 1.90259757 |
| 120 | Stereotypic behavior (HP:0000733) | 1.89992708 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.89152399 |
| 122 | Cerebral hemorrhage (HP:0001342) | 1.88147615 |
| 123 | Abnormal hair whorl (HP:0010721) | 1.87433834 |
| 124 | Acute encephalopathy (HP:0006846) | 1.87277357 |
| 125 | Hyperthyroidism (HP:0000836) | 1.86613460 |
| 126 | Sensorimotor neuropathy (HP:0007141) | 1.86481779 |
| 127 | Impaired vibratory sensation (HP:0002495) | 1.86151438 |
| 128 | Thickened helices (HP:0000391) | 1.86012991 |
| 129 | Papilledema (HP:0001085) | 1.85763764 |
| 130 | Ketoacidosis (HP:0001993) | 1.85724018 |
| 131 | Agitation (HP:0000713) | 1.84352979 |
| 132 | Exotropia (HP:0000577) | 1.84066353 |
| 133 | Tongue fasciculations (HP:0001308) | 1.82652601 |
| 134 | Iris hypopigmentation (HP:0007730) | 1.82131750 |
| 135 | Specific learning disability (HP:0001328) | 1.81111550 |
| 136 | Abnormal neuron morphology (HP:0012757) | 1.80535357 |
| 137 | Abnormality of the motor neurons (HP:0002450) | 1.80535357 |
| 138 | Sensory axonal neuropathy (HP:0003390) | 1.77884687 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77550260 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77550260 |
| 141 | Failure to thrive in infancy (HP:0001531) | 1.76886042 |
| 142 | Fair hair (HP:0002286) | 1.76682865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.96278729 |
| 2 | EPHA4 | 3.79925841 |
| 3 | MAP3K12 | 3.31309678 |
| 4 | FRK | 3.29666790 |
| 5 | RIPK4 | 3.22446840 |
| 6 | MAP3K4 | 3.22446836 |
| 7 | MAP3K9 | 3.21785658 |
| 8 | TRIM28 | 3.12305332 |
| 9 | CASK | 3.11461581 |
| 10 | PNCK | 3.08309093 |
| 11 | MAP2K7 | 2.82609870 |
| 12 | MINK1 | 2.42983524 |
| 13 | PLK2 | 2.39657317 |
| 14 | MARK1 | 2.18508428 |
| 15 | ERBB3 | 2.16374717 |
| 16 | MAP2K4 | 2.14481211 |
| 17 | GRK5 | 1.92970978 |
| 18 | ARAF | 1.89742053 |
| 19 | OXSR1 | 1.88375358 |
| 20 | NTRK1 | 1.79991105 |
| 21 | KSR2 | 1.72997923 |
| 22 | PINK1 | 1.72737225 |
| 23 | DAPK2 | 1.63185440 |
| 24 | CDK19 | 1.58721527 |
| 25 | FGR | 1.52689189 |
| 26 | PAK6 | 1.50973422 |
| 27 | NTRK2 | 1.49261985 |
| 28 | CSNK1G1 | 1.46106198 |
| 29 | CSNK1A1L | 1.44160576 |
| 30 | BMPR2 | 1.42265974 |
| 31 | MAP4K2 | 1.40552966 |
| 32 | ACVR1B | 1.38464562 |
| 33 | STK39 | 1.35587846 |
| 34 | KSR1 | 1.34438417 |
| 35 | DAPK1 | 1.34291727 |
| 36 | FES | 1.33856671 |
| 37 | NME1 | 1.32994076 |
| 38 | CDK5 | 1.32977611 |
| 39 | PTK2B | 1.32625045 |
| 40 | MAP3K13 | 1.29776505 |
| 41 | TNIK | 1.29577626 |
| 42 | CAMK2A | 1.26384658 |
| 43 | FGFR2 | 1.19405288 |
| 44 | PRKCG | 1.17707846 |
| 45 | CAMK2B | 1.13647180 |
| 46 | EPHA3 | 1.03823970 |
| 47 | GRK7 | 1.02341272 |
| 48 | SIK2 | 1.00823740 |
| 49 | MAP3K2 | 0.97964330 |
| 50 | MAPK13 | 0.97254119 |
| 51 | YES1 | 0.97128692 |
| 52 | LMTK2 | 0.95717820 |
| 53 | CAMKK2 | 0.93701703 |
| 54 | PRPF4B | 0.93365122 |
| 55 | CSNK1G2 | 0.90819476 |
| 56 | EIF2AK3 | 0.88562282 |
| 57 | BMPR1B | 0.87800959 |
| 58 | WNK4 | 0.87598089 |
| 59 | PRKCE | 0.84630501 |
| 60 | CAMKK1 | 0.84259740 |
| 61 | BCR | 0.84031062 |
| 62 | CDK14 | 0.83744756 |
| 63 | UHMK1 | 0.82048765 |
| 64 | CAMK2D | 0.81606685 |
| 65 | GRK6 | 0.81433370 |
| 66 | STK38L | 0.80671218 |
| 67 | WNK3 | 0.80437000 |
| 68 | CDK18 | 0.77840958 |
| 69 | RAF1 | 0.76505165 |
| 70 | MAPKAPK5 | 0.74873528 |
| 71 | CDK15 | 0.74420710 |
| 72 | SGK223 | 0.74053334 |
| 73 | SGK494 | 0.74053334 |
| 74 | DYRK1A | 0.69424954 |
| 75 | FER | 0.67756974 |
| 76 | SGK3 | 0.66842363 |
| 77 | PAK3 | 0.65940806 |
| 78 | ROCK2 | 0.65451243 |
| 79 | LATS2 | 0.64700477 |
| 80 | FGFR3 | 0.64522919 |
| 81 | DYRK2 | 0.63834895 |
| 82 | MAP3K6 | 0.63703225 |
| 83 | STK24 | 0.63395313 |
| 84 | CDK11A | 0.62131269 |
| 85 | EIF2AK1 | 0.61837235 |
| 86 | MAP3K5 | 0.61806340 |
| 87 | AKT3 | 0.61357166 |
| 88 | SGK1 | 0.60494679 |
| 89 | RET | 0.59338341 |
| 90 | STK38 | 0.59187149 |
| 91 | CAMK2G | 0.57916685 |
| 92 | NEK6 | 0.57907851 |
| 93 | CAMK1G | 0.56413692 |
| 94 | RPS6KB1 | 0.54059468 |
| 95 | ADRBK1 | 0.53398607 |
| 96 | ADRBK2 | 0.53239493 |
| 97 | PLK3 | 0.53188593 |
| 98 | TYRO3 | 0.53127254 |
| 99 | CSNK1G3 | 0.51960128 |
| 100 | STK11 | 0.50245735 |
| 101 | TAF1 | 0.48895257 |
| 102 | MAP3K1 | 0.48772782 |
| 103 | PDPK1 | 0.47461662 |
| 104 | PDK3 | 0.46608012 |
| 105 | PDK4 | 0.46608012 |
| 106 | SCYL2 | 0.46426958 |
| 107 | FYN | 0.46298446 |
| 108 | PRKACB | 0.45933601 |
| 109 | CSNK1D | 0.45444666 |
| 110 | MAP2K1 | 0.45315255 |
| 111 | CAMK1 | 0.45195867 |
| 112 | BRAF | 0.44777933 |
| 113 | PKN1 | 0.44568664 |
| 114 | WNK1 | 0.44353395 |
| 115 | MOS | 0.44254999 |
| 116 | CCNB1 | 0.42469526 |
| 117 | MUSK | 0.41809312 |
| 118 | CSNK1A1 | 0.41032710 |
| 119 | SGK2 | 0.40945262 |
| 120 | PDK1 | 0.38566367 |
| 121 | PHKG1 | 0.37607377 |
| 122 | PHKG2 | 0.37607377 |
| 123 | TAOK1 | 0.37504491 |
| 124 | PRKCZ | 0.36173205 |
| 125 | PRKG2 | 0.36018750 |
| 126 | DYRK3 | 0.35362085 |
| 127 | TRPM7 | 0.34281044 |
| 128 | LIMK1 | 0.33539602 |
| 129 | TSSK6 | 0.32733703 |
| 130 | PDK2 | 0.32639491 |
| 131 | * PRKACA | 0.32509152 |
| 132 | ALK | 0.32459317 |
| 133 | PRKCH | 0.32358559 |
| 134 | SIK3 | 0.32123630 |
| 135 | TGFBR2 | 0.30300699 |
| 136 | PRKG1 | 0.29878926 |
| 137 | PRKAA1 | 0.28634246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.10771947 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.42576770 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.84407405 |
| 4 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.81060570 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62318325 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61674406 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.39046632 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.35111633 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34898094 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33518015 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19953686 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.19061468 |
| 13 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16720711 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08773039 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.02718819 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.97932503 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.94647787 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92280830 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.89590916 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.84682055 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81967740 |
| 22 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.72220679 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69229815 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.68742978 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67469866 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56213757 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.55043839 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.52461344 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49429690 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48825853 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48062249 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41567301 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37725987 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35293938 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35160505 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33618632 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33094353 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32370856 |
| 39 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31464386 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29543145 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27219207 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25486951 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24975107 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.20217671 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.18389654 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13452050 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12861103 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08659803 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.05196815 |
| 50 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02529587 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01612339 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98292909 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97093299 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.97054505 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90754063 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89839368 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89658837 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87637288 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85581121 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84051377 |
| 61 | Melanogenesis_Homo sapiens_hsa04916 | 0.83854095 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.83836198 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83103459 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82496512 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77957669 |
| 66 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77357670 |
| 67 | * Phagosome_Homo sapiens_hsa04145 | 0.77035273 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76737304 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75784191 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74261090 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73295695 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69938266 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68364639 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68296924 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67470111 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67001115 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63836856 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63782654 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62901131 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62424213 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61312783 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60952394 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59599846 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 0.59313181 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59191271 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58133624 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56027033 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54328189 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52681025 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52027473 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50298133 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49185903 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46844706 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46250281 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45252101 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45070048 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44565366 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43571921 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.43257236 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43159069 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.41166641 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40745887 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40697388 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.38213999 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37857338 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.37020488 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37020377 |
| 108 | Peroxisome_Homo sapiens_hsa04146 | 0.36941909 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36125754 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35970255 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35816010 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34809262 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33349334 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.33305888 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.31383539 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30901086 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28557612 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.28383300 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28297935 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28158860 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21498615 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19625682 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19454922 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.18507574 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17717045 |
| 126 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.17192409 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16502699 |

